Matches in SemOpenAlex for { <https://semopenalex.org/work/W338509063> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W338509063 abstract "Abstract : Autism spectrum disorder (ASD) is a disease of development characterized by three core behavioral symptoms including difficulties in social interaction, verbal and nonverbal communication and repetitive/stereotypical behaviors. The Department of Health and Human Services states that the increasing prevalence of ASDs, currently estimated at 1 in 88 children, is a national health emergency. Yet there are no drugs for the treatment of these core deficits or associated neurological/medical symptoms such as epilepsy and anxiety. Consequently, ASD is a dire unmet medical need. The greatest challenge is to find a drug with a broad range of activity that will treat both the core symptoms and associated difficulties (i.e., epilepsy, anxiety, disrupted learning and memory). The objective of our project is to fulfill this profound need for drugs that can do exactly that by studying a new class of compounds that will simultaneously enhance the function of two neurotransmitters in the brain known as -aminobutyric acid (GABA) and acetylcholine (ACh). GABA acting through GABAA receptors (GABAARs) is responsible for reducing the activity of nerve cells in the brain that may be overstimulated in ASD and thus contributes to the three core symptoms and the anxiety and epilepsy that sometimes occur in ASD. ACh acting through a7 nicotinic receptors (a7 nAChRs) control the activity of nerve cells in the brain that may be under-stimulated in ASD which may underlie the difficulties in learning and memory observed in ASD. This approach may provide the basis for the design of an innovative series of drugs acting simultaneously at both receptors and will thus represent the first attempt at treating the core and significant comorbidities of ASD with a single drug." @default.
- W338509063 created "2016-06-24" @default.
- W338509063 creator A5057160626 @default.
- W338509063 date "2014-08-01" @default.
- W338509063 modified "2023-09-23" @default.
- W338509063 title "Dual Modulators of GABA-A and Alpha7 Nicotinic Receptors for Treating Autism" @default.
- W338509063 cites W1993056315 @default.
- W338509063 cites W2117928188 @default.
- W338509063 cites W2154767575 @default.
- W338509063 doi "https://doi.org/10.21236/ada610984" @default.
- W338509063 hasPublicationYear "2014" @default.
- W338509063 type Work @default.
- W338509063 sameAs 338509063 @default.
- W338509063 citedByCount "0" @default.
- W338509063 crossrefType "report" @default.
- W338509063 hasAuthorship W338509063A5057160626 @default.
- W338509063 hasConcept C118552586 @default.
- W338509063 hasConcept C126322002 @default.
- W338509063 hasConcept C15744967 @default.
- W338509063 hasConcept C169760540 @default.
- W338509063 hasConcept C170493617 @default.
- W338509063 hasConcept C188987157 @default.
- W338509063 hasConcept C205778803 @default.
- W338509063 hasConcept C2778186239 @default.
- W338509063 hasConcept C2778538070 @default.
- W338509063 hasConcept C558461103 @default.
- W338509063 hasConcept C71924100 @default.
- W338509063 hasConceptScore W338509063C118552586 @default.
- W338509063 hasConceptScore W338509063C126322002 @default.
- W338509063 hasConceptScore W338509063C15744967 @default.
- W338509063 hasConceptScore W338509063C169760540 @default.
- W338509063 hasConceptScore W338509063C170493617 @default.
- W338509063 hasConceptScore W338509063C188987157 @default.
- W338509063 hasConceptScore W338509063C205778803 @default.
- W338509063 hasConceptScore W338509063C2778186239 @default.
- W338509063 hasConceptScore W338509063C2778538070 @default.
- W338509063 hasConceptScore W338509063C558461103 @default.
- W338509063 hasConceptScore W338509063C71924100 @default.
- W338509063 hasLocation W3385090631 @default.
- W338509063 hasOpenAccess W338509063 @default.
- W338509063 hasPrimaryLocation W3385090631 @default.
- W338509063 hasRelatedWork W180247906 @default.
- W338509063 hasRelatedWork W1977676880 @default.
- W338509063 hasRelatedWork W1987695713 @default.
- W338509063 hasRelatedWork W2034357979 @default.
- W338509063 hasRelatedWork W2048222841 @default.
- W338509063 hasRelatedWork W2082369948 @default.
- W338509063 hasRelatedWork W2083594694 @default.
- W338509063 hasRelatedWork W2100527931 @default.
- W338509063 hasRelatedWork W2126143811 @default.
- W338509063 hasRelatedWork W2128784337 @default.
- W338509063 hasRelatedWork W2145054656 @default.
- W338509063 hasRelatedWork W2331911504 @default.
- W338509063 hasRelatedWork W2472844507 @default.
- W338509063 hasRelatedWork W2559241475 @default.
- W338509063 hasRelatedWork W2753542395 @default.
- W338509063 hasRelatedWork W2896027036 @default.
- W338509063 hasRelatedWork W2932310602 @default.
- W338509063 hasRelatedWork W2971611057 @default.
- W338509063 hasRelatedWork W3037282097 @default.
- W338509063 hasRelatedWork W3130087712 @default.
- W338509063 isParatext "false" @default.
- W338509063 isRetracted "false" @default.
- W338509063 magId "338509063" @default.
- W338509063 workType "report" @default.